MSD has decided to abandon the development of its anti-TIGIT antibody vibostolimab and anti-LAG-3 antibody favezelimab, blowing a hole in its immuno-oncology pipeline. The demise of the two programmes ...
The Rasmussen Reports daily Presidential Tracking Poll for Wednesday shows that 48% of Likely U.S. Voters approve of President Trump’s job performance. Fifty (50%) disapprove. The latest figures ...
The Rasmussen Reports daily Presidential Tracking Poll for Monday shows that 48% of Likely U.S. Voters approve of President Trump’s job performance. Fifty (50%) disapprove. The latest figures include ...
View post: The Ram Dakota Is Back — and It Looks Like a Baby Ram 1500 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback